# Oral Helicobacter Pylori Eradication

> **NCT06045832** · NA · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 42 (estimated)

## Conditions studied

- H. Pylori Infection

## Interventions

- **DEVICE:** MAXPOWER Biological Antibacterial Liquid
- **DEVICE:** Water

## Key facts

- **NCT ID:** NCT06045832
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-09-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06045832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06045832, "Oral Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06045832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*